Contribution: Industrial Research Assistance Program – Contributions to Firms
PulseMedica Corp.
$335,000.00
OSNAT 800 Prototype Development version 2.0
FY 2020-21 · 2021-02-01
Summary
PulseMedica aims to redesign and develop a more advanced medical device prototype to be used to perform more precise retinal surgery than is a current standard in medical practice. Advancements for the proprietary real-time 3D imaging and laser targeting system include enhanced image acquisition, higher speed and resolution.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Edmonton|Edmonton, Alberta, Canada
Recipient Type
For-profit organization
Business Number
776889289
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2021-02-01 | 2020-21 | $240,000.00 |
| 1 | 2021-02-01 | 2020-21 | $300,000.00 |
| 2 | 2021-02-01 | 2020-21 | $335,000.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The total amended value is 35,000 dollars.
Additional Information (French)
Cet accord a été modifié 1 fois La valeur totale des modifications est de 35 000 dollars.
Agreement End Date
2022-03-31
Agreement Number
967434
Agreement Start Date
2021-02-01
Agreement Title
OSNAT 800 Prototype Development version 2.0
Agreement Title (French)
Mise au point du prototype OSNAT 800 version 2.0
Agreement Type
Contribution
Agreement Value
$335,000.00
Amendment Date
2022-03-15
Amendment Number
2
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
PulseMedica aims to redesign and develop a more advanced medical device prototype to be used to perform more precise retinal surgery than is a current standard in medical practice. Advancements for the proprietary real-time 3D imaging and laser targeting system include enhanced image acquisition, higher speed and resolution.
Description (French)
PulseMedica vise à reconcevoir et à mettre au point un prototype de dispositif médical plus avancé qui sera utilisé pour effectuer une chirurgie rétinienne plus précise que ce qui est actuellement la norme dans la pratique médicale. Les avancées pour le système propriétaire d'imagerie 3D en temps réel et de ciblage laser comprennent une acquisition d'image améliorée, une vitesse et une résolution plus élevées.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Edmonton Riverbend
Federal Riding (French)
Edmonton Riverbend
Federal Riding Number
48018
NAICS Code
334512
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
776889289
Recipient City
Edmonton|Edmonton
Recipient Country
CA
Recipient Legal Name
PulseMedica Corp.
Recipient Postal Code
T6J 2V2
Recipient Province or Territory
AB
Recipient Type
F
Reference Number
172-2020-2021-Q4-967434
